APVO
Aptevo Therapeutics Inc.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $3.98
- As of
Share the APVO intelligence card
See APVO live in the terminal
Track APVO's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live APVO terminal, freeActive signals for APVO
- mediumEARNINGS_BEAT
Q2-2025: Beat consensus by 90.1% - EPS $-151.2 vs $-1527.552 estimate
- mediumEARNINGS_MISS
Q1-2026: Missed consensus by 12.2% - EPS $-6.41 vs $-5.712 estimate
- mediumEARNINGS_BEAT
Beat consensus by 90.1% - EPS $-151.2 vs $-1527.552 estimate
- mediumEARNINGS_BEAT
Q3-2025: Beat consensus by 12.7% - EPS $-33.48 vs $-38.3724 estimate
- mediumEARNINGS_BEAT
Q4-2025: Beat consensus by 99.9% - EPS $-0.01 vs $-8.2518 estimate
Top institutional holders of APVO (13F)
| Fund | Market value | % portfolio | QoQ |
|---|---|---|---|
| Point72 Asset Management, L.P. | $435K | 0.00% | , |
Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.
Recent SEC filings, APVO
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
Catch the next move on names like this
New 13F filings, insider trades, and cross asset signals like the ones above, in your inbox each morning or live on Telegram. Free, no account.
One email a day. Unsubscribe anytime. We never sell your data.
See more APVO signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to APVOand get the insider, 13F, options, and confluence read in one view.